CVS Health (NYSE:CVS) announced in a Sept. 10 company statement that Mary Langowski has been appointed executive VP of strategy, policy and market development, effective October 14.
Langowski will direct CVS Health's strategy and market development functions, with a focus on identifying and expanding enterprise opportunities to new markets as the company enhances its commitment to proactive involvement in the health care industry.
Previously, Langowski led CVS government affairs and policy development teams at the state and federal level, providing strategic counsel as CVS navigated policies, regulations and market trends affecting the company's focus on health care.
"As health care continues to evolve, CVS Health is committed to delivering solutions for better health to our customers and the patients we serve," said Thomas Moriarty, executive VP, chief health care strategy officer and general counsel at CVS Health. "We need a leader who understands our business fundamentals and how they intersect with health care policy and the political landscape.
Langowski comes to CVS from international firm DLA Piper, where she has acted as the chair of the Health Care Policy and Regulatory Practice and the co-chair of the Food and Beverage Sector. Her experience spans the private, non-profit and public sectors.
CVS changed its name from CVS Caremark to CVS Health on Sept. 3 in the wake of a driving commitment to promoting customer health on all fronts—namely the omission of tobacco products from store inventory henceforth.
The company also launched a comprehensive no-smoking campaign intended to help Americans kick the unhealthy habit. The program has included the combined efforts of the pharmacy, minuteclinic and caremark branches, a strategic pivot that's oversight will ultimately be delegated at least in part to Langowski. Press Release